{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:55:44Z","timestamp":1780322144204,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hellenic Journal of Cardiology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.hjc.2023.06.007","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T18:01:42Z","timestamp":1688407302000},"page":"58-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Pharmacological management of dilated cardiomyopathy in Duchenne muscular dystrophy: A systematic review"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3840-2134","authenticated-orcid":false,"given":"Christien Noel","family":"Haddad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demetra","family":"Stephanou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Stordahl","family":"Assakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilit","family":"Sahagian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4496-777X","authenticated-orcid":false,"given":"Efstratios","family":"Trogkanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hjc.2023.06.007_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11897-020-00456-0","article-title":"Duchenne muscular dystrophy: the heart of the matter","volume":"17","author":"Shih","year":"2020","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.hjc.2023.06.007_bib2","first-page":"3186","article-title":"Duchenne dilated cardiomyopathy: cardiac management from prevention to advanced cardiovascular therapies","volume":"9","author":"Adorisio","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.hjc.2023.06.007_bib3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4330\/wjc.v7.i7.410","article-title":"Cardiac involvement in Duchenne and Becker muscular dystrophy","volume":"7","author":"Mavrogeni","year":"2015","journal-title":"World J Cardiol"},{"key":"10.1016\/j.hjc.2023.06.007_bib4","article-title":"A\u00a0randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in duchenne muscular dystrophy","volume":"vol. 5","author":"Allen","year":"2013","journal-title":"PLoS Curr"},{"key":"10.1016\/j.hjc.2023.06.007_bib5","first-page":"72","article-title":"Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy","volume":"53","author":"Ogata","year":"2009","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.hjc.2023.06.007_bib6","first-page":"24","article-title":"Treatment of dystrophinopathic cardiomyopathy: review of the literature and personal results","volume":"31","author":"Politano","year":"2012","journal-title":"Acta Myolog"},{"key":"10.1016\/j.hjc.2023.06.007_bib7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/cvr\/cvz109","article-title":"Absence of full-length dystrophin impairs normal maturation and contraction of cardiomyocytes derived from human-induced pluripotent stem cells","volume":"116","author":"Pioner","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hjc.2023.06.007_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1745-7599.2009.00404.x","article-title":"Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy","volume":"21","author":"Kaspar","year":"2009","journal-title":"J\u00a0Am Acad Nurse Pract"},{"key":"10.1016\/j.hjc.2023.06.007_bib9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/ppul.25175","article-title":"Cardiac medication management in Duchenne muscular dystrophy","volume":"56","author":"Wittekind","year":"2021","journal-title":"Pediat Pulmonol"},{"key":"10.1016\/j.hjc.2023.06.007_bib10","first-page":"101","article-title":"The use of \u03b2-blockers in heart failure with reduced ejection fraction","volume":"8","author":"Masarone","year":"2021","journal-title":"J\u00a0Cardiovasc Dev Dis"},{"key":"10.1016\/j.hjc.2023.06.007_bib11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/joim.12944","article-title":"Dilated cardiomyopathy: from epidemiologic to genetic phenotypes: a translational review of current literature","volume":"286","author":"Reichart","year":"2019","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.hjc.2023.06.007_bib12","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.3390\/ijms20174098","article-title":"Cardiac pathophysiology and the future of cardiac therapies in Duchenne muscular dystrophy","volume":"20","author":"Meyers","year":"2019","journal-title":"Int J Molecul Sci"},{"key":"10.1016\/j.hjc.2023.06.007_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-017-0771-9","article-title":"Effects of RAAS inhibitors in patients with kidney disease","volume":"19","author":"Zhang","year":"2017","journal-title":"Curr Hyperten Rep"},{"key":"10.1016\/j.hjc.2023.06.007_bib14","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/eurjhf\/hft052","volume":"15","author":"McMurray","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hjc.2023.06.007_bib15","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1046\/j.1523-1755.2000.00983.x","article-title":"Mineralocorticoid receptor antagonists: the evolution of utility and pharmacology","volume":"57","author":"Delyani","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.hjc.2023.06.007_bib16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijchv.2014.03.005","article-title":"Mineralocorticoid receptor antagonist in heart failure: Past, present and future perspectives","volume":"3","author":"Vizzardi","year":"2014","journal-title":"IJC Heat Vessel"},{"key":"10.1016\/j.hjc.2023.06.007_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hjc.2023.06.007_bib18","first-page":"S466","article-title":"The role of prophylactic heart failure therapy in duchenne muscular dystrophy","volume":"38","author":"Lal","year":"2019","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hjc.2023.06.007_bib19","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1542\/peds.2018-0333I","article-title":"Cardiac management of the patient with Duchenne muscular dystrophy","volume":"142","author":"Buddhe","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.hjc.2023.06.007_bib20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jacc.2004.09.078","article-title":"Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy","volume":"45","author":"Duboc","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hjc.2023.06.007_bib21","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ahj.2007.05.014","article-title":"Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years\u2019 follow-up","volume":"154","author":"Duboc","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.hjc.2023.06.007_bib22","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jamacardio.2016.4801","article-title":"Myocardial fibrosis progression in Duchenne and Becker muscular dystrophy: a randomized clinical trial","volume":"2","author":"Silva","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hjc.2023.06.007_bib23","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.1212\/CPJ.0000000000001023","article-title":"Preventing cardiomyopathy in DMD: a randomized placebo-controlled drug trial","volume":"11","author":"Bourke","year":"2021","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.hjc.2023.06.007_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-019-1066-9","article-title":"Effect and safety of treatment with ACE-inhibitor Enalapril and \u03b2-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy-a randomized, double-blind, placebo-controlled trial","volume":"14","author":"Dittrich","year":"2019","journal-title":"Orphan J Rare Dis"},{"key":"10.1016\/j.hjc.2023.06.007_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1474-4422(14)70318-7","article-title":"Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial","volume":"14","author":"Raman","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.hjc.2023.06.007_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-017-0590-8","article-title":"Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: results of a two-year open-label extension trial","volume":"12","author":"Raman","year":"2017","journal-title":"Orphan J Rare Dis"},{"key":"10.1016\/j.hjc.2023.06.007_bib27","article-title":"Stabilization of early Duchenne cardiomyopathy with aldosterone inhibition: results of the multicenter AIDMD trial","volume":"8","author":"Raman","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.hjc.2023.06.007_bib28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4070\/kcj.2012.42.3.184","article-title":"The effect of enalapril and carvedilol on left ventricular dysfunction in middle childhood and adolescent patients with muscular dystrophy","volume":"42","author":"Kwon","year":"2012","journal-title":"Korean Circulat J"},{"key":"10.1016\/j.hjc.2023.06.007_bib29","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1253\/circj.70.991","article-title":"Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy","volume":"70","author":"Kajimoto","year":"2006","journal-title":"Circulat J"},{"key":"10.1016\/j.hjc.2023.06.007_bib30","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1002\/ehf2.13963","article-title":"Angiotensin receptor-neprilysin inhibitor in symptomatic patients with Duchenne dilated cardiomyopathy: A primetime","volume":"9","author":"Arcudi","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.hjc.2023.06.007_bib31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijcard.2019.01.052","article-title":"Heart rate reduction strategy using ivabradine in end-stage Duchenne cardiomyopathy","volume":"280","author":"Adorisio","year":"2019","journal-title":"Int J Cardiol"}],"container-title":["Hellenic Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966623001124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966623001124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:15:59Z","timestamp":1761099359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1109966623001124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":31,"alternative-id":["S1109966623001124"],"URL":"https:\/\/doi.org\/10.1016\/j.hjc.2023.06.007","relation":{},"ISSN":["1109-9666"],"issn-type":[{"value":"1109-9666","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological management of dilated cardiomyopathy in Duchenne muscular dystrophy: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Hellenic Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hjc.2023.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Hellenic Society of Cardiology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}